EyePoint Pharmaceuticals
EYPT
#5182
Rank
ยฃ1.13 B
Marketcap
ยฃ13.70
Share price
2.93%
Change (1 day)
97.42%
Change (1 year)

Revenue for EyePoint Pharmaceuticals (EYPT)

Revenue in 2025 (TTM): ยฃ32.76 Million

According to EyePoint Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is ยฃ31.77 Million. In 2024 the company made a revenue of ยฃ34.48 Million a decrease over the revenue in the year 2023 that were of ยฃ36.12 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for EyePoint Pharmaceuticals from 2003 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ32.76 M-4.99%
2024 ยฃ34.48 M-4.53%
2023 ยฃ36.12 M5.54%
2022 ยฃ34.22 M25.06%
2021 ยฃ27.36 M8.32%
2020 ยฃ25.26 M62.69%
2019 ยฃ15.52 M
2017 ยฃ1.93 M-65.36%
2016 ยฃ5.57 M377.62%
2015 ยฃ1.16 M-93.54%
2014 ยฃ18.05 M1257.53%
2013 ยฃ1.33 M-9.48%
2012 ยฃ1.46 M-64.11%
2011 ยฃ4.09 M-63.1%
2010 ยฃ11.09 M35.99%
2009 ยฃ8.15 M32.55%
2008 ยฃ6.15 M1528.21%
2007 ยฃ0.37 M-64.06%
2006 ยฃ1.05 M33.89%
2005 ยฃ0.78 M249.03%
2004 ยฃ0.22 M126.71%
2003 ยฃ0.09 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NRC Health
NRC
ยฃ0.10 B 228.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas